Log In
BCIQ
Print this Print this
 

KamRab (human anti-rabies IgG therapy)

Also known as: KedRAB

  Manage Alerts
Collapse Summary General Information
Company Kamada Ltd.
DescriptionAnti-rabies IgG
Molecular Target Not applicable
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentMarketed
Standard IndicationRabies
Indication DetailsPost-exposure prophylaxis of rabies infection
Regulatory Designation
PartnerKedrion Group S.p.A.;
Vitel Laboratorios S.A. de C.V.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

11/03/2016

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today